NRXP is reaching its 52week low and what goes down must go up & vice-versa in the market...the long wick inverted candle looks like this may have some momentum on the upside if the phase 2 and 3 trials go well for is COVID-19 lung respiratory issues and Bipolar acute suicide medication will be useful for both mental and physiological health...stochastic looks like it is making movements but the momentum is on a flag but an uptick...Very volatile and FDA approval will be the major factor for this stock as it returns to its 52 week low...only long due to the technicals but phase 2 & 3 trials will be the major growth/mom factor for this stock...
